Baird Maintains Outperform on Bio-Techne, Raises Price Target to $81
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Catherine Schulte maintains an Outperform rating on Bio-Techne (NASDAQ:TECH) and raises the price target from $73 to $81.
May 02, 2024 | 10:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Catherine Schulte maintains an Outperform rating on Bio-Techne and raises the price target from $73 to $81.
The increase in price target by Baird reflects a positive outlook on Bio-Techne's performance, suggesting potential upside for the stock. This analyst endorsement could lead to increased investor confidence and a short-term rise in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100